Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AR/101 for Re-epithelialization of Split Thickness Wounds
NCT02602184Phase 2Unknown
- Sponsor
- Arava Bio Tech
- Start
- Nov 2015
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of enzastaurin, sponsored by Arava Bio Tech. Status: unknown.
02
Drugs
enzastaurin
Beyond the preview
Go deeper on NCT02602184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02602184.